HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of specific binding of 3H-phorbol dibutyrate to Friend leukemia cells.

Abstract
The nature of phorbol ester receptors in intact Friend erythroid leukemia cells (FLC) was examined by utilizing 3H-phorbol dibutyrate (3H-PDBu). FLC were shown to possess one class of specific and saturable 3H-PDBu receptors with high affinity, that is, with a Kd of 14.1 +/- 4.2 nM and 1.1 X 10(5) +/- 0.22 binding sites/cell, as revealed by Scatchard analysis. The specific phorbol ester binding activity of FLC was shown to be phospholipid-dependent, since it was sensitive to treatment of the cells with phospholipase A2 or C and also was inhibited competitively by phospholipid-interacting agents such as antipsychotic or anticalmodulin drugs. The relative potency of the drugs for the inhibition of PDBu binding to FLC was parallel to that for the inhibition of protein kinase C.
AuthorsK Tanaka, T Ono
JournalGan (Gan) Vol. 74 Issue 6 Pg. 837-44 (Dec 1983) ISSN: 0016-450X [Print] Japan
PMID6141978 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antipsychotic Agents
  • Caenorhabditis elegans Proteins
  • Calmodulin
  • Carrier Proteins
  • Phorbol Esters
  • Phorbols
  • Receptors, Cell Surface
  • Receptors, Drug
  • phorbol ester binding protein
  • phorbol ester receptor
  • Phorbol 12,13-Dibutyrate
  • Protein Kinase C
  • Phospholipases
  • Neuraminidase
Topics
  • Animals
  • Antipsychotic Agents (pharmacology)
  • Binding Sites
  • Caenorhabditis elegans Proteins
  • Calmodulin (antagonists & inhibitors)
  • Carrier Proteins
  • Cell Line
  • Depression, Chemical
  • Friend murine leukemia virus
  • Kinetics
  • Leukemia, Experimental (metabolism)
  • Mice
  • Neuraminidase (pharmacology)
  • Phorbol 12,13-Dibutyrate
  • Phorbol Esters (metabolism)
  • Phorbols (metabolism)
  • Phospholipases (pharmacology)
  • Protein Kinase C
  • Receptors, Cell Surface (metabolism)
  • Receptors, Drug

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: